期刊文献+

microRNA-31在原发性肺癌组织中的表达及临床意义 被引量:9

Expression and Clinical Significance of microRNA-31 in Primary Lung Cancer Tumor Tissues
下载PDF
导出
摘要 目的检测肺癌组织及癌旁正常组织中miR-31的表达情况与肺癌的诊断、肿块大小、淋巴结转移、吸烟及分期的关系。方法采用quantitative real-time RT-PCR方法对75例肺癌患者术后癌组织及癌旁正常组织中miR-31的表达量进行检测。结果 miR-31在癌组织中的相对表达量是癌旁正常组织的6.48倍(P<0.001)。吸烟患者miR-31的表达量是不吸烟患者的3.06倍(P=0.033)。在NSCLC中,与肿瘤长径≤3 cm肿瘤相比,长径>3 cm肿瘤中miR-31的表达量较高(P=0.045)。无论淋巴结转移与否,其表达量差异无统计学意义(P=0.703)。结论 miR-31在肺癌组织中高表达、在不同肿块中表达的差异以及与吸烟的关系,提示其可能成为肺癌的筛查、诊断及预测肿块大小的一个生物标志物。 Objective Detected the miR-31 expresssion level in tumor tissues and adjacent normal tissues to observe the relationship between miR-31 and the screening diagnosis of lung cancer.Methods Using quantitative real-time RT-PCR to assess the miR-31 expression in lung cancer tumor tissues and adjacent normal tissues.Results The relative expression level of miR-31 is 6.48 folds in tumor tissues compared to adjacent normal tissues(P0.001).The level in smoke patients specimen is 3.06 folds to non-smoke.The expression level of tumor major axis3 cm is higher than major axis≤3 cm in NSCLC(P=0.033).Whether the lymph nodes metastasis or not,there is no difference between them.Conclusion The outcomes that miR-31 was overexpressed in lung cancer,and the difference in accordance with tumor major axis as well as the relationship with cigarettes indicated miR-31 might be a biomarker for screening,diagnosis,and predicting the tumor axis.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2012年第3期281-284,共4页 Cancer Research on Prevention and Treatment
基金 2011年河南省基础与前沿技术研究计划资助项目(112300410033) 河南省卫生科技创新型人才工程专项经费资助项目(201052) 河南省医学学术技术带头人出国培训项目
关键词 肺癌 MIRNA miR-31 诊断 生物标志物 Lung cancer miRNA miR-31 Diagnosis Biomarker
  • 相关文献

参考文献1

二级参考文献20

  • 1Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262. 被引量:1
  • 2Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86. 被引量:1
  • 3Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184. 被引量:1
  • 4Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962. 被引量:1
  • 5Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269. 被引量:1
  • 6Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866. 被引量:1
  • 7Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179. 被引量:1
  • 8Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9. 被引量:1
  • 9Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12. 被引量:1
  • 10Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-2261. 被引量:1

共引文献981

同被引文献99

  • 1杨玲,李连弟,陈育德,Donald Maxwell Parkin.中国肺癌死亡趋势分析及发病、死亡的估计与预测[J].中国肺癌杂志,2005,8(4):274-278. 被引量:168
  • 2郦俊,张惠兰.缺氧诱导因子在肺癌组织中的表达及其临床意义[J].山东医药,2006,46(27):35-36. 被引量:1
  • 3俞焙秦,刘炳亚.miRNA的生物学特性和功能[J].上海交通大学学报(医学版),2007,27(5):621-623. 被引量:30
  • 4Chen CZ. MicroRNAs as oncogenes and tumor suppressors. N Engl J Med,2005,353(17) :1768-1771. 被引量:1
  • 5Guarnieri DJ, DiLeone RJ. MicroRNAs: a new class of gene regulators. Ann Med, 2008,40 ( 3 ) : 197-208. 被引量:1
  • 6Valastyan S, Weinberg RA. miR-31 : a crucial overseer of tumor metastasis and other emerging roles. Cell Cycle, 2010,9 ( 11 ) : 2124-2129. 被引量:1
  • 7Cekaite L, Rantala JK, Bruun J, et al. MiR-9,-31, and-182 deregulation promote proliferation and tumor cell survival in colon cancer. Ncoplasia,2012,14(9) :868-879. 被引量:1
  • 8Lajer CB, Nielsen FC, Friis-Hansen L, et al. Different miRNAsignatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. Br J Cancer, 2011,104 ( 5 ) : 830-840. 被引量:1
  • 9Kozaki K, Imoto I, Mogi S, et al. Exploration of tumor- suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res ,2008,68 ( 7 ) :2094-2105. 被引量:1
  • 10Liu CJ, Lin SC, Yang CC, et al. Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma. Head Neck, 2012,34(2 ) :219-224. 被引量:1

引证文献9

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部